561 related articles for article (PubMed ID: 11363197)
1. [Update on HIV pathogenesis].
Detres LL
Sidahora; 1995; ():13-4. PubMed ID: 11363197
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.
Sankatsing SU; van Praag RM; van Rij RP; Rientsma R; Jurriaans S; Lange JM; Prins JM; Schuitemaker H
Antivir Ther; 2003 Apr; 8(2):137-42. PubMed ID: 12741626
[TBL] [Abstract][Full Text] [Related]
3. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?
Grossman Z; Meier-Schellersheim M; Sousa AE; Victorino RM; Paul WE
Nat Med; 2002 Apr; 8(4):319-23. PubMed ID: 11927927
[No Abstract] [Full Text] [Related]
5. HIV preferentially infects HIV-specific CD4+ T cells.
Douek DC; Brenchley JM; Betts MR; Ambrozak DR; Hill BJ; Okamoto Y; Casazza JP; Kuruppu J; Kunstman K; Wolinsky S; Grossman Z; Dybul M; Oxenius A; Price DA; Connors M; Koup RA
Nature; 2002 May; 417(6884):95-8. PubMed ID: 11986671
[TBL] [Abstract][Full Text] [Related]
6. How far can you knock down HIV? An interview with David D. Ho, MD. Interview by Mark Mascolini.
Ho DD
J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):40-4. PubMed ID: 11364429
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
Beq S; Delfraissy JF; Theze J
Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636
[TBL] [Abstract][Full Text] [Related]
8. Natural history and pathogenesis of human immunodeficiency virus infection.
Burger S; Poles MA
Semin Liver Dis; 2003 May; 23(2):115-24. PubMed ID: 12800065
[TBL] [Abstract][Full Text] [Related]
9. To kill or be killed: how HIV exhausts the immune system.
Gougeon ML
Cell Death Differ; 2005 Aug; 12 Suppl 1():845-54. PubMed ID: 15832178
[No Abstract] [Full Text] [Related]
10. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
11. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
12. Endocytosis of HIV: anything goes.
Permanyer M; Ballana E; Esté JA
Trends Microbiol; 2010 Dec; 18(12):543-51. PubMed ID: 20965729
[TBL] [Abstract][Full Text] [Related]
13. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
Sarmati L; Nicastri E; Montano M; Dori L; Buonomini AR; d'Ettorre G; Gatti F; Parisi SG; Vullo V; Andreoni M
J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751
[TBL] [Abstract][Full Text] [Related]
14. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
Aiuti F; Mezzaroma I
AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
[TBL] [Abstract][Full Text] [Related]
15. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
Furrer H; Barloggio A; Egger M; Garweg JG;
Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
[TBL] [Abstract][Full Text] [Related]
16. HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death.
Funk GA; Oxenius A; Fischer M; Opravil M; Joos B; Flepp M; Weber R; Günthard HF; Bonhoeffer S
J Med Virol; 2006 Sep; 78(9):1141-6. PubMed ID: 16847964
[TBL] [Abstract][Full Text] [Related]
17. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
[TBL] [Abstract][Full Text] [Related]
18. The mucosal immune system and HIV-1 infection.
Veazey R; Lackner A
AIDS Rev; 2003; 5(4):245-52. PubMed ID: 15012003
[TBL] [Abstract][Full Text] [Related]
19. In search of the Holy Grail: Martin Markowitz, M.D., on the dream of eradication.
Markowitz M
Res Initiat Treat Action; 1998 Apr; 4(2):9-13. PubMed ID: 11365230
[TBL] [Abstract][Full Text] [Related]
20. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART.
Jones LE; Perelson AS
Bull Math Biol; 2005 Nov; 67(6):1227-51. PubMed ID: 16023709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
